Creatine for Women: the cognition and bone data

Creatine monohydrate is the most-studied supplement in sports nutrition — over 1,000 human trials, a consistent safety profile, and a price point that hasn't budged in years. What has changed is the reason to take it. The data now extends well beyond the weight room, and women are underrepresented in most of the older strength research anyway.

This piece walks through what the newer literature says about creatine and cognition, sleep-deprived brain function, mood, and — most interestingly — bone mineral density in postmenopausal women. We'll also cover why the "loading phase" is optional and why women may actually need a slightly higher daily dose than men.

What creatine actually does, in plain English

Creatine is a small molecule your liver and kidneys make from three amino acids (arginine, glycine, methionine). You also get about 1–2 grams a day from red meat and fish. It's stored mostly in skeletal muscle as phosphocreatine, where it acts as a rapid-recycle system for ATP — the cell's energy currency.

Here's the part most people miss: your brain uses ATP too. Neurons are metabolically expensive, and the brain holds its own creatine pool. When that pool is topped up, cognitive tasks that demand fast ATP turnover — working memory, mental math, reaction time under fatigue — tend to run better.

Women typically store about 70–80% of the creatine men do at baseline, largely because dietary intake is lower on average and endogenous synthesis is modest. That baseline gap is part of why supplementation effects can show up more clearly in women in some trials.

The cognition data: what actually changes

A 2023 systematic review in Nutrients (Prokopidis et al.) pooled 16 randomized trials and found creatine supplementation improved memory performance, particularly in adults over 60 and in tasks involving short-term recall. Effect sizes were modest but consistent.

More striking is the sleep-deprivation work. A 2024 trial in Scientific Reports (Gordji-Nejad et al.) gave a single high dose of creatine to sleep-deprived subjects and measured cognitive performance and brain energy metabolism via MRS imaging. Processing speed and short-term memory improved within a few hours, alongside measurable shifts in brain phosphocreatine and pH.

That's not a claim that creatine fixes bad sleep. It's a signal that when the brain is metabolically stressed — poor sleep, high cognitive load, aging — a topped-up creatine pool has more to give.

If you've ever noticed your worst thinking happens on your worst-slept days, creatine is one of the few supplements with mechanistic data pointing at that exact problem.

Creatine and bone density in postmenopausal women

This is the finding that deserves more attention than it gets. In a 12-month randomized controlled trial by Chilibeck and colleagues (published in Medicine & Science in Sports & Exercise, 2015), postmenopausal women doing resistance training plus 0.1 g/kg/day of creatine preserved femoral neck bone mineral density and improved bone geometry compared to placebo plus training.

The placebo group lost bone at the hip over the year. The creatine group didn't. In a demographic where hip fracture is a genuine mortality event, that's a meaningful signal — not a cure for osteoporosis, but a plausible adjunct to resistance training and any prescribed bone therapy.

The mechanism is likely indirect: creatine lets women train harder and recover better, and mechanical loading is the primary driver of bone remodeling. Some in-vitro work also suggests direct effects on osteoblast activity, but the training-quality pathway is the cleanest explanation.

{callout: The takeaway} For women over 40, creatine's most interesting data isn't about muscle size — it's about preserving cognitive performance under stress and supporting bone density when paired with resistance training.

Mood, depression, and hormonal transitions

Smaller trials have looked at creatine as an adjunct in major depressive disorder, particularly in women. A 2012 study in the American Journal of Psychiatry (Lyoo et al.) added 5 g/day of creatine to SSRI treatment in women with MDD and found faster and greater improvement in depression scores versus SSRI plus placebo over 8 weeks.

This is not a stand-alone antidepressant claim, and creatine should not replace prescribed treatment. But the brain-energy hypothesis of depression — that some depressive symptoms track with impaired cellular energy metabolism — gives a coherent reason why an ATP-buffering compound might help at the margins.

For women navigating perimenopause, where mood, sleep, and cognition often shift together, creatine is a low-risk piece of the stack worth discussing with a clinician who knows your context.

Dosing: skip the loading phase

The classic protocol — 20 g/day for 5–7 days, then 3–5 g/day — was designed to saturate muscle stores quickly for athletic performance. It works, but it also causes GI upset in a meaningful fraction of users and isn't necessary if you're not chasing a competition timeline.

Standard published maintenance dosing:

• 3–5 g/day of creatine monohydrate for most adults
• 5 g/day is a reasonable target for women, given lower baseline stores
• Some cognition and bone research has used 0.1 g/kg/day (roughly 6–8 g for many women)
• Timing doesn't matter much — daily consistency does
• Take it with a meal if it upsets your stomach

Saturation on 5 g/day takes about 3–4 weeks. Effects on cognition and training capacity build gradually over that window.

What form to buy

Creatine monohydrate is the form with the actual research behind it. "Creatine HCl," "buffered creatine," "creatine ethyl ester" — these are marketing categories with thinner evidence and higher price tags. Micronized monohydrate mixes better in water but is chemically identical.

Look for a product with third-party testing (NSF Certified for Sport or Informed Sport) if you compete in a tested sport or just want assurance on purity.

Safety, side effects, and the kidney myth

The kidney concern comes from a misreading of creatinine — a breakdown product of creatine that shows up on standard blood panels. Supplementing creatine mildly elevates serum creatinine without reflecting actual kidney injury. In people with healthy kidneys, long-term creatine use has not been associated with renal dysfunction in the trials that have looked (including studies out to 5 years).

If you have preexisting kidney disease, that's a conversation for your clinician, not a supplement to self-start.

Water retention is real but modest — typically 1–2 pounds of intracellular water in the first few weeks, not the bloated puffiness people fear. GI upset resolves for most people by taking it with food and skipping the loading phase.

If you're considering creatine alongside a serious protocol — hormone therapy, GLP-1s, a structured training block — the labs worth having on hand are a basic metabolic panel (kidney function), a CBC, and whatever hormonal markers are relevant to your situation. Context helps a clinician tune the plan; it isn't a gate to trying a well-studied supplement.

Who probably shouldn't bother

Creatine isn't magic and it isn't for everyone:

• If you eat a lot of red meat and fish and don't train, your baseline may already be high enough that supplementation moves the needle less.
• If you're not doing any resistance training, the bone and muscle benefits largely evaporate — creatine amplifies training, it doesn't replace it.
• If you have active kidney disease or are on dialysis, don't self-start.

For most women over 30 who train, want to protect cognitive performance, and are thinking about bone health for the next 40 years — the risk-to-benefit math is unusually favorable for a supplement this cheap.

The bottom line

Creatine monohydrate has moved from a gym supplement to a legitimate longevity tool, particularly for women. The cognition data is strongest when the brain is stressed (sleep loss, aging, high demand). The bone data is meaningful when paired with resistance training. The mood data is preliminary but mechanistically coherent.

Five grams a day, monohydrate form, taken consistently, no loading phase required. Pair it with training you actually do, and reassess after 8–12 weeks.

Editorial disclosure: This article is for informational purposes only and does not constitute medical advice. All treatments at DirectCare AI are prescribed by US-licensed clinicians based on individual medical evaluation. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Always consult a US-licensed clinician before starting or changing any therapy.